无菌性全髋翻修术后延长抗生素预防无获益:配对病例对照研究
该研究回顾性配对分析了2000年1月至2015年12月间接受无菌性全髋关节翻修术的患者,将209例接受延长抗生素预防(>24小时)者与209例接受标准预防(≤24小时)者按年龄、性别、体质指数、Charlson合并症指数和手术时间1:1配对。结果显示延长预防组后续假体周围感染发生率为4.8%,标准预防组为2.4%;多因素logistic回归校正混杂因素后,延长预防并未降低后续感染发生率。结论认为,对于无菌性失败的全髋翻修术患者,将围手术期抗生素预防延长至术中培养结果回报似乎不提供额外获益。
要点
- 延长抗生素预防组后续假体周围感染发生率为4.8%,标准预防组为2.4%。
- 多因素logistic回归校正混杂因素后,延长预防未降低后续感染发生率。
- 两组无感染植入物生存率相似:延长组95.2%,标准组97.6%。
核心结论
- 对于无菌性失败的全髋翻修术患者,将围手术期抗生素预防延长至术中培养结果回报似乎在降低后续假体周围感染风险方面不提供额外获益。
研究设计与样本
- 回顾性配对病例对照研究,纳入2000年1月至2015年12月间接受无菌性全髋翻修术的患者。
- 将209例接受延长抗生素预防(>24小时)的患者与209例接受标准抗生素预防(≤24小时)的患者按1:1比例配对。
- 配对标准为年龄、性别、体质指数、Charlson合并症指数和手术时间。
主要发现
- 延长抗生素预防组后续假体周围感染发生率为4.8%,标准预防组为2.4%。
- 多因素logistic回归校正所有混杂因素后,延长预防性抗生素给药未降低后续感染发生率。
- 按术后抗生素方案分层,两组无感染植入物生存率相似:延长组95.2%,标准组97.6%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Administration of perioperative antibiotic prophylaxis is one of the most important practices for prevention of periprosthetic joint infection (PJI) in patients undergoing total hip arthroplasty (THA). It is common to continue perioperative antibiotic prophylaxis for 48 hours or longer in patients undergoing revision arthroplasty, until results of intraoperative culture samples become available. However, the utility of this practice remains unclear. We examined whether extended antibiotic prophylaxis following aseptic revision THA reduces the risk of subsequent PJI. METHODS: We retrospectively reviewed records of patients undergoing aseptic revision THA between January 2000 and December 2015. At our institution, some surgeons administer prophylactic antibiotics to revision patients for only 24 hours while others prefer to extend until intraoperative culture results become available. We matched 209 patients undergoing revision THA who received extended antibiotic prophylaxis (>24 hours) in a 1:1 ratio with 209 patients receiving standard antibiotic prophylaxis (≤24 hours). The matching criteria were age, sex, body mass index, Charlson comorbidity index, and operative time. RESULTS: The incidence of subsequent PJI was 4.8% in patients receiving extended antibiotic prophylaxis vs 2.4% in patients receiving standard. After adjusting for all cofounders and using multivariate logistic regression, the administration of extended prophylactic antibiotics did not reduce the incidence of subsequent infection. When stratified by postoperative antibiotic regimens, the 2 groups had similar infection-free implant survival rate (95.2% in extended and 97.6% in standard). CONCLUSION: It appears that extending perioperative prophylactic antibiotics until intraoperative culture results become available in patients undergoing revision THA for aseptic failures does not provide any additional benefit in terms of reducing the risk of subsequent PJI.
引用
- Kuo FC, Aalirezaie A, Goswami K, et al. Extended Antibiotic Prophylaxis Confers No Benefit Following Aseptic Revision Total Hip Arthroplasty: A Matched Case-Controlled Study. J Arthroplasty. 2019. PMID: 31266692. doi:10.1016/j.arth.2019.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。